A detailed history of Epoch Investment Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 841,110 shares of MRK stock, worth $82 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
841,110
Previous 1,344,097 37.42%
Holding current value
$82 Million
Previous $166 Million 42.6%
% of portfolio
0.44%
Previous 0.78%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $55.9 Million - $64.9 Million
-502,987 Reduced 37.42%
841,110 $95.5 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $15.7 Million - $16.9 Million
127,214 Added 10.45%
1,344,097 $166 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $68,170 - $79,433
602 Added 0.05%
1,216,883 $161 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $14.7 Million - $16 Million
-147,117 Reduced 10.79%
1,216,281 $133 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $1.78 Million - $1.97 Million
-17,274 Reduced 1.25%
1,363,398 $140 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $2.06 Million - $2.24 Million
-18,961 Reduced 1.35%
1,380,672 $159 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $2.06 Million - $2.3 Million
20,048 Added 1.45%
1,399,633 $149 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $46.9 Million - $60.1 Million
-536,467 Reduced 28.0%
1,379,585 $153 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $11.4 Million - $12.8 Million
-135,185 Reduced 6.59%
1,916,052 $165 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $81 Million - $91.8 Million
-969,709 Reduced 32.1%
2,051,237 $187 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $23.2 Million - $26.1 Million
316,207 Added 11.69%
3,020,946 $248 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $14.9 Million - $18.6 Million
205,551 Added 8.22%
2,704,739 $207 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $179 Million - $197 Million
2,499,188 New
2,499,188 $188 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $64.9 Million - $71.8 Million
-922,659 Reduced 28.07%
2,364,774 $184 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $25.8 Million - $30.4 Million
-374,439 Reduced 10.23%
3,287,433 $253 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $353 Million - $392 Million
-4,922,849 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $16.9 Million - $19.1 Million
-230,681 Reduced 4.48%
4,922,849 $408 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $97.9 Million - $111 Million
1,390,378 Added 36.95%
5,153,530 $399 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $27.7 Million - $38.4 Million
-436,869 Reduced 10.4%
3,763,152 $290 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $12.2 Million - $13.8 Million
-157,508 Reduced 3.61%
4,200,021 $382 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $43.7 Million - $47.6 Million
574,055 Added 15.17%
4,357,529 $367 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $10 Million - $11.7 Million
143,752 Added 3.95%
3,783,474 $317 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $60.2 Million - $68.7 Million
-865,334 Reduced 19.21%
3,639,722 $303 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $16.7 Million - $19.4 Million
-255,933 Reduced 5.38%
4,505,056 $344 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $7.24 Million - $8.52 Million
125,518 Added 2.71%
4,760,989 $338 Million
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $99.6 Million - $117 Million
1,959,318 Added 73.21%
4,635,471 $281 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $6.82 Million - $7.93 Million
-133,818 Reduced 4.76%
2,676,153 $146 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $466,076 - $556,547
-9,029 Reduced 0.32%
2,809,971 $158 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $165 Million - $178 Million
2,819,000
2,819,000 $181 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.